|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-5.51/-2.86
|
企业价值
298.90M
|
资产负债 |
每股账面净值
3.64
|
现金流量 |
现金流量率
--
|
损益表 |
收益
832.01K
|
每股收益
0.37
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/21 18:22 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies. |